Cargando…

IL-17A and TNF-α inhibitors induce multiple molecular changes in psoriasis

Adalimumab and secukinumab are commonly used for moderate to severe psoriasis vulgaris (PV). Although distinct individual responses to and impaired effectiveness of these biological agents occur occasionally, little is known about the underlying reasons. Here, we report a proteomic analysis of psori...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Qiang, Li, Dan, Xie, Bi Bo, Hu, Li Hua, Huang, Jia, Jia, Xiao Xiao, Tang, Yan Li, Liu, Gan Hong, Shen, Ning Ning, Yu, Xiao Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723344/ https://www.ncbi.nlm.nih.gov/pubmed/36483564 http://dx.doi.org/10.3389/fimmu.2022.1015182

Ejemplares similares

Ultraviolet B Inhibits IL-17A/TNF-α-Stimulated Activation of Human Dermal Fibroblasts by Decreasing the Expression of IL-17RA and IL-17RC on Fibroblasts
por: Yin, Li, et al.
Publicado: (2017)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis
por: Braga, Matheus, et al.
Publicado: (2021)

Association of the TNF-α, IL-2, and IL-2RB gene variants with susceptibility to psoriasis in a Turkish cohort
por: Gulel, Aslihan, et al.
Publicado: (2018)

Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis
por: Costache, Daniel Octavian, et al.
Publicado: (2022)

IL-17 and TNF-α Are Key Mediators of Moraxella catarrhalis Triggered Exacerbation of Allergic Airway Inflammation
por: Alnahas, Safa, et al.
Publicado: (2017)

Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors
por: Koike, Yuta, et al.
Publicado: (2020)

No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
por: Sikorska, Dorota, et al.
Publicado: (2018)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry
por: Lockshin, Benjamin, et al.
Publicado: (2021)

IL-17A and TNF-α Increase the Expression of the Antiapoptotic Adhesion Molecule Amigo-2 in Arthritis Synoviocytes
por: Benedetti, Giulia, et al.
Publicado: (2016)

TNFα-Signaling Modulates the Kinase Activity of Human Effector Treg and Regulates IL-17A Expression
por: Urbano, Paulo C. M., et al.
Publicado: (2020)

Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis via Crosstalk With Keratinocytes by Releasing IL-17A
por: Liu, Xiu-ting, et al.
Publicado: (2022)

Additive or Synergistic Interactions Between IL-17A or IL-17F and TNF or IL-1β Depend on the Cell Type
por: Noack, Mélissa, et al.
Publicado: (2019)

Differential Effects of IL-17A and TNF-α on Osteoblastic Differentiation of Isolated Synoviocytes and on Bone Explants from Arthritis Patients
por: Osta, Bilal, et al.
Publicado: (2015)

Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)

2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells
por: Le, Stephanie T., et al.
Publicado: (2019)

Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review
por: Wang, Jiao, et al.
Publicado: (2023)

Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A–Producing γδ T Cells
por: Zhang, Song, et al.
Publicado: (2021)

Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients
por: Smail, Shukur Wasman, et al.
Publicado: (2023)

Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis
por: Shores, Lucas S., et al.
Publicado: (2020)

Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
por: Bugaut, Hélène, et al.
Publicado: (2021)

Psoriasis Is Associated With Elevated Gut IL-1α and Intestinal Microbiome Alterations
por: Yegorov, Sergey, et al.
Publicado: (2020)

Human IL-17 and TNF-α Additively or Synergistically Regulate the Expression of Proinflammatory Genes, Coagulation-Related Genes, and Tight Junction Genes in Porcine Aortic Endothelial Cells
por: Li, Weilong, et al.
Publicado: (2022)

Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
por: Jiraskova Zakostelska, Zuzana, et al.
Publicado: (2023)

Effects of paraquat on IL-6 and TNF-α in macrophages
por: Huang, Jie, et al.
Publicado: (2019)

Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin
por: Kim, Jaehwan, et al.
Publicado: (2023)

Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity
por: Arican, Ozer, et al.
Publicado: (2005)

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients
por: Shi, Yuling, et al.
Publicado: (2019)

Depression and Obesity in Patients With Psoriasis and Psoriatic Arthritis: Is IL-17-Mediated Immune Dysregulation the Connecting Link?
por: Zafiriou, Efterpi, et al.
Publicado: (2021)

Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis
por: Liu, Meitong, et al.
Publicado: (2022)

Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients
por: Furiati, Sandro C., et al.
Publicado: (2019)

Diagnostic Value of sIL-2R, TNF-α and PCT for Sepsis Infection in Patients With Closed Abdominal Injury Complicated With Severe Multiple Abdominal Injuries
por: Zhai, Guang-hua, et al.
Publicado: (2021)

Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels
por: Meira, Cristina S., et al.
Publicado: (2014)

Interleukin-35 Inhibits TNF-α-Induced Osteoclastogenesis and Promotes Apoptosis via Shifting the Activation From TNF Receptor-Associated Death Domain (TRADD)–TRAF2 to TRADD–Fas-Associated Death Domain by JAK1/STAT1
por: Peng, Mingzheng, et al.
Publicado: (2018)

Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation
por: Roy, Tithi, et al.
Publicado: (2023)

Therapeutic Potential of TNFα and IL1β Blockade for CRS/ICANS in CAR-T Therapy via Ameliorating Endothelial Activation
por: Chen, Yunshuo, et al.
Publicado: (2021)

Role of Interleukin-17A in the Pathomechanisms of Periodontitis and Related Systemic Chronic Inflammatory Diseases
por: Feng, Yi, et al.
Publicado: (2022)

Association Analysis of IL10, TNF-α, and IL23R-IL12RB2 SNPs with Behçet’s Disease Risk in Western Algeria
por: Khaib Dit Naib, Ouahiba, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j1uhccu05pg5cr2o0153aie5s2